A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday.
The U.S. Food and Drug Administration approved Eli Lilly’s drug, named Zepbound. The drug, also known as tirzepatide, helped dieters lose as much as 40 to 60 pounds in testing.
I know that it’s a lifelong drug. I don’t care. I’ll take it. Especially because of the evened out crashes! Not having a sugar high or a sugar low is so wonderful for someone who has spent 37 years enslaved to snacks.